Your browser doesn't support javascript.
loading
Frequency and Type of Red Flags in Patients With Covid-19 and Headache: A Series of 104 Hospitalized Patients.
García-Azorín, David; Trigo, Javier; Talavera, Blanca; Martínez-Pías, Enrique; Sierra, Álvaro; Porta-Etessam, Jesús; Arenillas, Juan F; Guerrero, Ángel L.
Afiliação
  • García-Azorín D; Headache Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Trigo J; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Talavera B; Headache Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Martínez-Pías E; Headache Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Sierra Á; Headache Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Porta-Etessam J; Headache Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Arenillas JF; Headache Unit, Department of Neurology, Institute of Neurosciences, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
  • Guerrero ÁL; Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
Headache ; 60(8): 1664-1672, 2020 09.
Article em En | MEDLINE | ID: mdl-32790215
ABSTRACT

OBJECTIVE:

In this study, we aimed to evaluate the frequency of the main red flags in patients with headache who do have Covid-19.

BACKGROUND:

Headache is one of the most frequent neurologic symptoms of Coronavirus disease 2019 (Covid-19). Diagnosis of secondary headache disorders is still based on the presence of red flags. DESIGN AND

METHODS:

Cross-sectional study of hospitalized patients with confirmed Covid-19 disease. We interrogated every patient about the presence of headache and if so, a headache expert conducted a structured interview assessing the presence and type of the main red flags. We evaluated the presence of laboratory abnormalities on admission.

RESULTS:

We screened 576 consecutive patients, 130/576 (22.6%) described headache, and 104 were included in the study. Mean age of patients was 56.7 (standard deviation 11.2) and 66/104 (63.4%) were female. Red flags concerning prior medical history were present in 79/104 (76.0%) cases, and those related to the headache itself were observed in 99/104 (95.2%) patients. All patients 104/104 (100%) described systemic symptoms and 86/104 (82.7%) some neurologic symptoms. Laboratory results were abnormal in 98/104 (94.2%) cases. The most frequent red flags were fever, in 93/104 (89.4%) patients, cough, in 89/104 (85.6% cases), and increased C-reactive protein in 84/100 (84.0%) cases.

CONCLUSION:

In patients with Covid-19 that described the headache red flags were present in most cases. There was not any universal red flag, being necessary the comprehensive evaluation of all of them.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína C-Reativa / Tosse / Transtornos da Cefaleia Secundários / Febre / SARS-CoV-2 / COVID-19 / Pacientes Internados / Doenças do Sistema Nervoso Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Headache Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína C-Reativa / Tosse / Transtornos da Cefaleia Secundários / Febre / SARS-CoV-2 / COVID-19 / Pacientes Internados / Doenças do Sistema Nervoso Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Headache Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha